Larimar Therapeutics (LRMR) Shares Outstanding (2016 - 2020)
Historic Shares Outstanding for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $15.4 million.
- Larimar Therapeutics' Shares Outstanding rose 15210.27% to $15.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $15.4 million, marking a year-over-year increase of 15210.27%. This contributed to the annual value of $6.1 million for FY2019, which is 0.0% changed from last year.
- Latest data reveals that Larimar Therapeutics reported Shares Outstanding of $15.4 million as of Q3 2020, which was up 15210.27% from $15.4 million recorded in Q2 2020.
- In the past 5 years, Larimar Therapeutics' Shares Outstanding registered a high of $36.9 million during Q3 2018, and its lowest value of $6.1 million during Q4 2018.
- Moreover, its 5-year median value for Shares Outstanding was $15.4 million (2020), whereas its average is $16.5 million.
- As far as peak fluctuations go, Larimar Therapeutics' Shares Outstanding tumbled by 8347.72% in 2019, and later surged by 15210.27% in 2020.
- Larimar Therapeutics' Shares Outstanding (Quarter) stood at $27.3 million in 2016, then increased by 0.57% to $27.5 million in 2017, then plummeted by 77.84% to $6.1 million in 2018, then changed by 0.0% to $6.1 million in 2019, then skyrocketed by 152.1% to $15.4 million in 2020.
- Its Shares Outstanding stands at $15.4 million for Q3 2020, versus $15.4 million for Q2 2020 and $6.1 million for Q1 2020.